Skip to Content
🌐Ship toSelect country

Stylage M - 2 x 1,0ml

Stylage M is the non-lidocaine version of Stylage Bi-Soft M, a Laboratoires Vivacy cross-linked hyaluronic acid filler (20mg/g HA) with mannitol, designed for immediate correction of superficial-to-moderate lines and wrinkles including smaller nasolabial folds, marionette lines and nose/earlobe reshaping, as well as hand rejuvenation. Reported results last up to 12 months. For use by licensed, trained medical professionals only.

104.00 € 104.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand STYLAGE®
SKU A5216 Share
Treatment Areas Crow's FeetLipsMarionette LinesMentolabial foldsMouthNasolabial foldsNose
Tags Cross-Linked Hyaluronic AcidFine Lines

Stylage M is Laboratoires Vivacy's original (pre-Bi-Soft) monophasic, antioxidant cross-linked hyaluronic acid gel at 20mg/g, built on IPN-Like technology with mannitol, designed for correction of moderate to deep facial wrinkles including nasolabial folds and lip or nasal reshaping.

CONCENTRATION

  • Cross-linked hyaluronic acid 20mg/g (IPN-Like technology) + mannitol

THE PACK INCLUDES

  • 2 x 1.0ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

One injection per year is typically sufficient to restore sagging skin and fill facial depressions.

INDICATIONS

  • Moderate to deep facial wrinkles
  • Nasolabial folds
  • Lip and nasal reshaping

TREATMENT AREAS

  • Nasolabial folds
  • Lips
  • Face, general

Stylage M is injected into the mid to deep dermis using linear threading or fanning technique.

Results are visible immediately, with final results assessed after 1-2 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin